CompletedNCT06648668
A Study to Investigate the Interaction Between TMP-301 and Cocaine.
Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Overland ParkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: January 4, 2025
- Recruitment status
- Completed
- Enrollment listed in the registry
- 18
- Sponsor
- Tempero Bio, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT06648668
- Official title
Show the full official title
A Randomized, Participant- and Investigator-blinded, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral TMP-301 Given Concurrently With Cocaine
Get this study by email
Recruitment & locations
CompletedOverland Park
Questions about this study
Who is behind this study?
The study sponsor is Tempero Bio, Inc.
Did this study involve medication?
Yes. The study involved medication, including TMP-301 and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
